Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Preethi Sudheer"'
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 11, Iss 4, Pp 651-662 (2021)
Purpose: The present study focuses on a systemic approach to develop liposomal aztreonam as a promising dosage form for inhalation therapy in the treatment of pneumonia and explores the in-vitro antimicrobial and cell uptake efficacy. Methods: Liposo
Externí odkaz:
https://doaj.org/article/322e32acb0944be8b4c004fcb8092a78
Publikováno v:
Pharmaceutical Nanotechnology. 11:238-264
Abstract: The intestinal lymphatics are considered one of the most specialized pathways, which promote the absorption of various agents such as vitamins, lipids, xenobiotics, and lipophilic substances. The intestinal lymphatics have provided various
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f1e705d24d0d75491ab794b0a2d333c
https://doi.org/10.2174/2211738511666230112123235
https://doi.org/10.2174/2211738511666230112123235
Autor:
J VENKATA KRISHNA, PREETHI SUDHEER
Publikováno v:
Journal of Research in Pharmacy. 27:595-608
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef389cfe723fd06eeb283b01945db966
https://doi.org/10.29228/jrp.342
https://doi.org/10.29228/jrp.342
Publikováno v:
Journal of Research in Pharmacy. 27:811-824
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63330b7d19c4e4cf8aff8901c9f4a78f
https://doi.org/10.29228/jrp.362
https://doi.org/10.29228/jrp.362
Publikováno v:
Indian Journal of Pharmaceutical Education and Research. 56:s189-s199
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45d18a2d080fb2208767f5cf7fd8b254
https://doi.org/10.5530/ijper.56.2s.90
https://doi.org/10.5530/ijper.56.2s.90
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 11, Iss 4, Pp 651-662 (2021)
Advanced Pharmaceutical Bulletin
Advanced Pharmaceutical Bulletin
Purpose: The present study focuses on a systemic approach to develop liposomal aztreonam as a promising dosage form for inhalation therapy in the treatment of pneumonia and explores the in-vitro antimicrobial and cell uptake efficacy. Methods: Liposo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e09e954ee872334e2277025dbe9960f1
https://apb.tbzmed.ac.ir/PDF/apb-11-651.pdf
https://apb.tbzmed.ac.ir/PDF/apb-11-651.pdf
Publikováno v:
Research Journal of Pharmacy and Technology. :3816-3820
Stavudine is synthetic analog of reverse transcriptase inhibitor possessing a short half-life of 0.8 to 1.5 hours. Therefore frequent administration of the medication is required which results in poor patient acceptability The following research work
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::682d0defe49ddb0c07b8fd4164d88a3e
https://doi.org/10.52711/0974-360x.2021.00661
https://doi.org/10.52711/0974-360x.2021.00661
Publikováno v:
Drug Metabolism Letters. 14:66-79
Background: Ezetimibe is a cholesterol-lowering agent with an oral bioavailability of 50% by virtue of its poor solubility and extensive hepatic and intestinal metabolism. Objective: The study aimed to overcome low bioavailability issues of ezetimibe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e8580f0920278165308da6aaf26cd16
https://doi.org/10.2174/1872312814666200901182517
https://doi.org/10.2174/1872312814666200901182517
Autor:
Preethi Sudheer, Puneeth Jayram
Publikováno v:
International Journal of Pharmaceutical Investigation. 10:246-252
Low aqueous solubility and concomitant oral bioavailability are the major glitches found in converting the active pharmaceutical ingredients to new pharmaceutical products. Many methods are in existence to improve the solubility of poorly water-solub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eade2fbda8cec76e520b9e9e375203ab
https://doi.org/10.5530/ijpi.2020.3.45
https://doi.org/10.5530/ijpi.2020.3.45
Publikováno v:
International Journal of Applied Pharmaceutics. :198-208
Objective: Nanostructured lipid carrier is an emerging lipid-derived delivery system that is rapidly gaining popularity due to the simplicity of the manufacturing technique. The primary task in formulating nanoparticles is to optimize the parameters
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7595529d2c9836d9fb9d8273bf6bdc71
https://doi.org/10.22159/ijap.2020v12i6.39565
https://doi.org/10.22159/ijap.2020v12i6.39565